Ergebnis ihrer Suche nach Mitteilungen

DGAP-News 19.08.19 14:03 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Inc. Announces the Issuance of 41,200,000 Uni[...]
DGAP-News 07.08.19 04:47 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Provides Corporate Update
DGAP-News 28.06.19 14:03 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces AGM Voting Results
DGAP-News 30.05.19 22:41 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces First Quarter 2019 Financial Results
DGAP-News 01.05.19 00:39 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces 2018 Year End Financial Results
DGAP-News 25.02.19 14:01 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Inc. Announces the Issuance of 14,400,000 Uni[...]
DGAP-News 19.02.19 12:01 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Inc. Announces Upsizing of Non-Brokered Priva[...]
DGAP-News 12.02.19 01:20 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Inc. Announces the Issuance of 4,000,000 Unit[...]
DGAP-News 01.02.19 02:07 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Inc. Announces Non-Brokered Private Placement[...]
DGAP-News 29.11.18 23:00 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Third Quarter 2018 Financial Result[...]
DGAP-News 15.11.18 14:01 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Provides Corporate Update, Including Drug Sup[...]
DGAP-News 23.10.18 14:00 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Oral Amphotericin B Clinical Adviso[...]
DGAP-News 02.10.18 14:00 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Provides Corporate Update
DGAP-News 06.09.18 14:00 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Additional Positive Pharmacokinetic[...]
DGAP-News 30.08.18 00:32 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Second Quarter 2018 Financial Resul[...]
DGAP-News 16.07.18 14:01 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Positive Secondary Endpoint and Adv[...]
DGAP-News 27.06.18 14:00 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Positive Clinical Outcome - Primary[...]
DGAP-News 20.06.18 14:00 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Provides Corporate Update, Announces Completi[...]
DGAP-News 30.05.18 22:19 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces First Quarter 2018 Financial Result[...]
DGAP-News 25.04.18 02:47 DGAP-News: iCo Therapeutics Inc.
iCo Therapeutics Announces Year End 2017 Financial Results

GBC-Fokusbox

Fonds Research 2019: S.E.A. Asian High Yield Bond bietet attraktive Investitionschance

Auch 2019 hat die GBC AG unter der Vielzahl an Publikumsfonds neun „Fonds Champions“ herausgefiltert. Darunter auch den S.E.A. Asian High Yield Bond (ISIN: LU1138637738), der eine gute Anlagechance anbietet mit einer Strategie, die kaum reproduzierbar ist. Insbesondere vor dem Hintergrund des anhaltenden Niedrigzinsniveaus sehen wir den Anleihefonds als äußerst attraktive Investitionschance, um nachhaltige und volatilitätsarme Renditen zu erzielen. Wir haben den S.E.A. Asian High Yield Bond mit 4 von 5 Falken eingestuft.

Aktueller Webcast

EQS Group AG

Conference Call zu den Halbjahreszahlen 2019

16. August 2019

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

21. August 2019